OverviewChartNewsTraderScreen

Reata Pharmaceuticals/  US75615P1030  /

NASDAQ
25/09/2023  22:00:00 Chg. - Volume Bid01:50:00 Ask01:50:00 High Low
172.3600USD - 1.99 mill.
Turnover: 301.65 mill.		 172.3600Bid Size: - 172.5000Ask Size: - 172.4600 172.3200
GlobeNewswire 29/04 Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answer...
GlobeNewswire 15/04 Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
GlobeNewswire 15/02 BioNTX Champions Talent Retention in the Texas Life Sciences Industry
GlobeNewswire 05/02 MBX Biosciences Appoints Steven Ryder, M.D., to Board of Directors
GlobeNewswire 05/02 Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
GlobeNewswire 23/01 Alkeus Pharmaceuticals Appoints Seemi Khan, M.D., Chief Medical Officer
GlobeNewswire 11/12/2023 BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs
GlobeNewswire 16/10/2023 Pliant Therapeutics Appoints S. Mishima Gerhart as Chief Regulatory Officer
GlobeNewswire 26/09/2023 Biogen Completes Acquisition of Reata Pharmaceuticals
GlobeNewswire 18/09/2023 STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – DBTX, RETA, VRTV, ...
GlobeNewswire 15/09/2023 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, CPRI, RETA
GlobeNewswire 12/09/2023 STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – VRTV, HCCI, RETA, ...
GlobeNewswire 06/09/2023 ALERT: The M&A Class Action Firm Continues Investigating the Merger – NEWR, AMNB, DBTX, RETA
GlobeNewswire 29/08/2023 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DBTX, AMED, RETA, SURF
GlobeNewswire 29/08/2023 Moore Kuehn Encourages AMED, DBTX, RETA, and SURF Investors to Contact Law Firm
GlobeNewswire 28/08/2023 ALERT: The M&A Class Action Firm Continues Investigating the Merger – SCU, AMNB, NEWR, RETA
GlobeNewswire 28/08/2023 Muscular Dystrophy Association Kicks Off 30 Days of Strength Campaign for National Muscular Dystroph...
GlobeNewswire 21/08/2023 ALERT: The M&A Class Action Firm Continues Investigating the Merger – AMNB, RETA, CIR, PRDS
GlobeNewswire 21/08/2023 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Earthstone ...
GlobeNewswire 20/08/2023 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RETA, AEL, PRDS, CELL
GlobeNewswire 17/08/2023 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Rest...
TeleTrader 28/07/2023 Biogen to acquire Reata for $7.3 billion in cash
GlobeNewswire 17/02/2022 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BHG, CHGG, FSLR, RETA INVESTORS of Lead Plaintiff Deadline in...
GlobeNewswire 16/02/2022 FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BHG, CHGG, F...
GlobeNewswire 15/02/2022 RETA 3-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals...